Clinuvel Pharmaceuticals Ltd
NASDAQ:CUVL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Clinuvel Pharmaceuticals Ltd
NASDAQ:CUVL
|
AU |
|
Leroy Seafood Group ASA
OTC:LYSFF
|
NO |
|
M
|
Marui Group Co Ltd
OTC:MAURY
|
JP |
|
Clinuvel Pharmaceuticals Ltd
F:UR9A
|
AU |
|
H
|
Henry Schein Inc
XHAM:HS2
|
US |
|
C
|
Clinuvel Pharmaceuticals Ltd
OTC:CLVLF
|
AU |
|
T
|
Toyota Tsusho Corp
F:9TO
|
JP |
|
C
|
Clinuvel Pharmaceuticals Ltd
SWB:UR9
|
AU |
|
E
|
Eventbrite Inc
F:EB4
|
US |
Intrinsic Value
Is CUVL undervalued or overvalued?
See the intrinsic value estimate for 
Clinuvel Pharmaceuticals Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
CUVL looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with CUVL’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Clinuvel Pharmaceuticals Does
Clinuvel Pharmaceuticals is a specialty drug company that makes treatments for rare skin and light-sensitivity disorders. Its best-known product is SCENESSE, a prescription medicine used to help people with erythropoietic protoporphyria, a condition that can make sunlight exposure painful and difficult to manage. The company also works on other therapies linked to skin protection and pigmentation.
- Headquarters
- Australia AU
- Employees
- 16
- IPO date
- Feb 13, 2001
Earnings Waterfall
Clinuvel Pharmaceuticals Ltd
The intrinsic value for Clinuvel Pharmaceuticals Ltd (CUVL) under the Base Case is hidden USD.
Compared with the current market price of 5.24 USD, the stock appears hidden.